We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Derivation of New Human Embryonic Stem Cell Lines: Identification of Instructive Factors for Germ Cells Development

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01165918
Recruitment Status : Unknown
Verified June 2010 by Soroka University Medical Center.
Recruitment status was:  Not yet recruiting
First Posted : July 20, 2010
Last Update Posted : July 20, 2010
Sponsor:
Collaborator:
Information provided by:

Study Description
Brief Summary:

The purpose of this study is

  1. To generate human embryonic stem cells lines (hESC) lines
  2. Study of the factors that contribute to differentiation towards germ cell.

Condition or disease
Normal Healthy Embryos

Study Design

Study Type : Observational
Estimated Enrollment : 50 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Basic Research. Unveiling Factors That Contribute to Germ Cell Differentiation
Study Start Date : October 2010
Groups and Cohorts

Group/Cohort
Donated embryos


Outcome Measures

Primary Outcome Measures :
  1. New hESC [ Time Frame: 1 year ]
    Donated embryos will be used for derivation of the Es cells


Secondary Outcome Measures :
  1. Factors that contribute to germ cells differentiation [ Time Frame: 4 years ]
    We shall employ the knowledge from a study of sperm differentiation in mice to instruct the differentiation of ES cells towards germ cells


Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   up to 4 Days   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
any donated embryo
Criteria

Inclusion Criteria:

  • any donated embryos

Exclusion Criteria:

  • not relevant
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01165918


Contacts
Contact: Eitan Lunenfeld, MD and Prof. - 972-8-6460058 lunenfld@bgumail.bgu.ac.il
Contact: Rivka Ofir 97286477272 rivir@bgu.ac.il

Locations
Israel
Soroka medical center Not yet recruiting
Beer Sheva, Israel, 84101
Contact: Rivka Ofir, PhD    972 8 6477272    rivir@bgu.ac.il   
Sub-Investigator: Rivka Ofir, PhD         
Sponsors and Collaborators
Soroka University Medical Center
Ben-Gurion University of the Negev
More Information

Responsible Party: Dr. Eitan Lunenfeld, Soroka Medical Center
ClinicalTrials.gov Identifier: NCT01165918     History of Changes
Other Study ID Numbers: Sor491210CTIL
First Posted: July 20, 2010    Key Record Dates
Last Update Posted: July 20, 2010
Last Verified: June 2010